THE COMPETITION BETWEEN METHYLMERCURY RISKS AND OMEGA-3 POLYUNSATURATED FATTY ACID BENEFITS: A REVIEW OF CONFLICTING EVIDENCE ON FISH CONSUMPTION AND CARDIOVASCULAR HEALTH. by LIPFERT, F.W. & SULLIVAN, T.M.
      
 
 
Notice: This manuscript has been authored by employees of Brookhaven Science Associates, LLC under Contract No. DE-AC02-
98CH10886 with the U.S. Department of Energy. The publisher by accepting the manuscript for publication acknowledges that 
the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the 
published form of this manuscript, or allow others to do so, for United States Government purposes. 
 
THE COMPETITION BETWEEN METHYLMERCURY RISKS AND OMEGA-
3 POLYUNSATURATED FATTY ACID BENEFITS:  A REVIEW OF 
CONFLICTING EVIDENCE ON FISH CONSUMPTION AND 
CARDIOVASCULAR HEALTH 
 
 
F. W. Lipfert and T. M. Sullivan 
 
 
 
Progress Report on Mercury Health Effects 
Prepared for 
the U.S. Department of Energy  
National Energy Technology Laboratory 
 
 
 
October 2006 
 
 
 
Environmental Sciences Department 
Environmental Research & Technology Division 
 
Brookhaven National Laboratory 
P.O. Box 5000 
Upton, NY 11973-5000 
www.bnl.gov 
 
   
 
BNL-77474-2007-IR
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCLAIMER 
 
This report was prepared as an account of work sponsored by an agency of the United States 
Government.  Neither the United States Government nor any agency thereof, nor any of their 
employees, nor any of their contractors, subcontractors, or their employees, makes any warranty, 
express or implied, or assumes any legal liability or responsibility for the accuracy, 
completeness, or any third party’s use or the results of such use of any information, apparatus, 
product, or process disclosed, or represents that its use would not infringe privately owned rights. 
Reference herein to any specific commercial product, process, or service by trade name, 
trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, 
recommendation, or favoring by the United States Government or any agency thereof or its 
contractors or subcontractors.  The views and opinions of authors expressed herein do not 
necessarily state or reflect those of the United States Government or any agency thereof.  
 
 
  
Abstract 
 
The health concerns of methylmercury (MeHg) contamination of seafood have recently been 
extended to include cardiovascular effects, especially premature mortality.  Although the fatty acids (fish 
oils) found in most species are thought to confer a wide range of health benefits, especially to the 
cardiovascular system, some epidemiological studies have suggested that such benefits may be offset by 
adverse effects of MeHg.  This comprehensive review is based on searches of the NIH MEDLINE database 
and compares and contrasts 145 published studies involving cardiovascular effects and exposures to 
mercury and other fish contaminants, intake of fatty acids including dietary supplements of fish oils, and 
rates of seafood consumption.  Since few of these studies include adequate simultaneous measurements of 
all of these potential predictor variables, we summarized their effects separately, across the available 
studies of each, and then drew conclusions based on the aggregated findings.  It is important to realize that 
studies of seafood consumption encompass the net effects of all of these predictor variables, but that 
seafood intake studies are rarely supported by human biomarker measurements that reflect the actual 
uptake of harmful as well as beneficial fish ingredients.  As a result, exposure measurement error is an 
issue when comparing studies and predictor variables.  It is also possible that the observed benefits of 
eating fish may relate more to the characteristics of the consumers than to those of the fish. 
We found the evidence for adverse cardiovascular effects of MeHg to be sparse and unconvincing.  
Studies of cardiovascular mortality show net benefits, and the findings of adverse effects are mainly limited 
to studies Finland at high mercury exposure levels. By contrast, a very consistent picture of beneficial 
effects is seen for fatty acids, after recognizing the effects of exposure uncertainties and the presence of 
threshold effects.  Studies based on measured biomarker levels are seen to be the most reliable and present 
a convincing picture of strong beneficial effects, especially for those causes of death involving cardiac 
arrhythmias.  This conclusion also extends to studies of fish-oil supplementation. 
 Studies based on fish consumption show mainly benefits from increased consumption.  This 
finding is supported by an ecological study at the national population level, for which the lifestyle effects 
that might be correlated with fish consumption within a given population would be expected to “average 
out” across nations. 
 Finally, the net survival benefits resulting from eating fish are consistent with studies involving 
complete diets, although benefits are also seen to accrue from reduced consumption of red meat and 
saturated fats. 
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1. Introduction 
 
1.1  Background 
Fish and seafood have long been recognized as important components of a healthy diet, including 
the “Mediterranean diet” that has been widely praised (American Heart Association, 2006; Kok and 
Kromhout, 2004).  Survival benefits have been shown at the population level by comparing international 
statistics, and at the individual level through cohort studies.  Recently, cautions have been raised because of 
the potential for adverse cardiovascular effects ascribed to methylmercury (MeHg), which is present at 
some level in all seafood, as are the polyunsaturated fatty acids (PUFAs) thought to confer cardiovascular 
benefits.  Salonen et al. (1995a) pointed out that “epidemiological studies have a limited ability to 
distinguish the effects of beneficial and harmful substances in the same foodstuff.”   However, the 
correlation (R) between blood concentrations of these two agents is not very strong (for example, R=0.35, 
as reported by Sakamoto et al., 2004).      
The specific PUFA compounds hypothesized to confer the most cardiovascular benefits have been 
identified as “omega-3” or “n-3”, and these hypotheses have been tested with clinical trials of dietary 
supplements of fish oils.  In order to allow consumers to choose wisely, it is important to balance these 
competing aspects of a seafood diet (Morrissey, 2006), and to recognize that other contaminants may be 
present in seafood, especially in farmed fish (Hayward et al., 2006). 
Although mercury contamination of seafood has largely been addressed as originating from air 
pollution, it has important distinctions from those of inhaled pollutants.  Methylmercury (MeHg) exposure 
is essentially limited to the dietary pathway, which means that exposure is largely voluntary and that 
substantial variations may be expected within any given population group.  Fortunately, reliable biomarkers 
are available for individuals, such as the Hg content of blood, hair, or toenail clippings, which is not the 
case for most conventional air pollutants.  Biomarkers for fatty acid intake are less readily available, and 
sampling may involve invasive procedures. 
Another important distinction for the dietary exposure pathway is the necessity to consider an 
individual’s entire diet, not just the intake rates of specific substances of interest. For example, people who 
rely heavily on seafood for protein may be less likely to consume red meat (Zhang et al., 1999), which has 
its own adverse health effects and for which biomarkers may be less available. In most developed 
countries, individuals consume a variety of seafood, comprising both fatty and lean species, so that 
statistics on overall fish consumption may be misleading. There is also evidence that nutrition may affect 
mercury toxicity (Clarkson and Strain, 2003).  Studies of entire populations (i.e., ecological studies) will 
capture the net effects of entire dietary patterns, while cohort studies must control for these dietary 
correlates as possible confounders, often relying on personal dietary recall.  The analysis of the Nurses 
Health Study cohort by Fung et al. (2001) recognized this and used factor analysis to synthesize two 
different dietary patterns, one of which was associated with significantly lower mortality.  
 
1.2   Findings from Previous Reviews 
The literature on the general topic of diet and health is quite extensive, including the various 
aspects of eating seafood.  A search of PubMed for papers with “fish consumption” and “cardiovascular” in 
their titles or abstracts, limited to English language review papers based on human subjects, yielded 33 
relevant review papers, beginning in the 1980s.  However, only five of them also referred to mercury or 
methylmercury, indicating that this notion of competing risks and benefits is relatively recent (since 
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~2003).  By the same token, the National Research Council’s 2000 monograph on the toxicological effects 
of methylmercury devoted only 4 of its 344 pages to human cardiovascular effects.   
The epidemiological literature on Hg toxicity tends to be diverse and contradictory; Jacobson 
(2001) proposes some criteria for evaluating conflicting observational studies and points out that there is 
often “limited control over confounding and other factors.”  For example, only a few of the published 
studies on cardiovascular effects have devoted the same care to assessing exposures to both MeHg and 
PUFAs.  Other important dietary elements and other fish contaminants have been largely neglected in 
observational studies.   There are perhaps an order of magnitude more published papers on fatty acids in 
general and on marine fatty acids in particular, but only a few deal specifically with both MeHg and the 
fatty acids found in fish.  Even fewer studies include other fish contaminants such as Pb or PCBs. 
The overall conclusions of recent review papers vary.  Systematic reviews and meta-analyses of 
dietary supplements of fish oils are discussed below (Section 3.3).   Levenson and Axelrad (2006) support 
the cardioprotective role of n-3 fatty acids, but caution that the methylmercury in some types of fish could 
attenuate those benefits.  They note that the literature is conflicting, but emphasize the most recent report 
on a cohort from eastern Finland (Virtanen et al., 2005) as “specifically designed to address this 
controversy.”  They recommend using an index of the ratio of fatty acids to mercury content as a guide to 
selecting the “best” fish species; salmon is the clear winner on this basis, with whiting, flounder, and 
pollock as much less desirable.  They do not specifically discuss the fresh-water predatory fish species 
consumed by the Finns upon which their cautionary study is based or the importance of absolute levels of 
fish oil and fish contaminants in causing effects. 
Virtanen et al. (2005, in press) review studies of the relationships between Hg and adverse 
cardiovascular disease (CVD) effects, with an emphasis on the four publications from the Finnish cohort 
study.  The mercury intake for these subjects was primarily from fresh-water species, but no other 
contaminants were considered.  They discuss potential cardiovascular mechanisms and call for further 
studies, in part to examine whether there may be other correlated CVD risk factors confounding the 
observed Hg effects.  They discuss the possibility of a threshold for Hg-cardiovascular effects, but conclude 
that the extant data are not sufficient to define it.  The possibility of a PUFA threshold was not mentioned.  
Konig et al. (2005) performed a meta-analysis of fatty-acid benefits and derived an overall dose-
response relationship for coronary heart disease mortality (CHD).  However, they declined to extend this 
paradigm to methylmercury risks, because the “available literature was judged inadequate for quantitative 
analysis.”  Part of the reason for this conclusion was the variety of Hg exposure metrics used in the various 
Hg studies; they made no effort to convert these data to a common metric.  There are also issues of 
nonlinearity (adverse effects at high doses).  Subsequent correspondence on this paper raised the question 
of other fish contaminants, especially in farmed species such as salmon (Foran et al., 2005). 
Van Oostdam et al. (2005) present an extensive review of various contaminants in the Canadian 
Arctic diet and conclude that cultural values must also be considered when dietary changes are 
recommended.  However, this review did not discuss possible offsetting benefits of PUFAs.  Hansen and 
Gilman (2005) contrasted Hg and PUFA effects but did not mention the other contaminants. 
Matthan et al. (2005) reviewed selected animal studies of omega-3 supplementation and concluded 
that fish oils protect against arrhythmias, but that  α-linolenic acid (an omega-3 PUFA derived from plants) 
does not. 
Mahaffey (2004) discusses the benefits of fatty acids in fish and the risks of methylmercury 
(emphasizing neurological effects) and provides some useful data on the relative contents of each for 
various fish and shellfish species (marine species only).  She also recommends that other fish contaminants 
like dioxins and pesticides be considered. 
Calder (2004) reviews fatty acid and fish oil studies involving both mortality and cardiovascular 
events as endpoints, without discussing the potential problems of fish contaminants.  This approach was 
also taken by the Holubs (2004).  Calder discusses potential mechanisms for the benefits of fatty acids, and 
the Holubs point out that the average intake of fatty acids in the U.S. population is well below 
recommended guidelines. 
Chan and Egeland (2004) emphasized studies suggesting that Hg exposure may attenuate the 
protective effect of fatty acids.  They point out that autopsy evidence of Hg accumulation in the heart 
supports this hypothesis, but that some studies conflict and some suggest an Hg exposure threshold for 
cardiovascular effects (Frustaci et al. [1999] also reported high levels of Hg in the heart muscles of some 
cardiac patients). 
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Kris-Etherton et al. (2003) present an “American Heart Association Scientific Statement” that 
recommends eating oily fish at least twice a week, but urge caution with respect to contaminants  like PCBs 
and Hg.  PCB exposures can be reduced by removing the fish skin and fat before cooking.  Mercury content 
relates to the type of fish; guidelines are available for pregnant women and young children.  They conclude 
that “Consumption of a wide variety of species within the guidelines is the best approach to both 
minimizing mercury exposure and increasing omega-3 fatty acid intake.” 
Castoldi et al. (2003) review the neurotoxic effects of MeHg, without mentioning cardiovascular 
effects, and discuss oxidative stress as an important mechanism. Marckmann and Gronbaek (1999) 
performed a systematic review of 11 studies of coronary heart disease mortality and concluded that benefits 
of fish consumption were limited to high-risk populations.  
Nakai and Satoh (2002) review neurological effects of fish contaminants, including an extensive 
discussion of PCBs, which they conclude should be considered in parallel with MeHg.  PCB exposures and 
health effects are reviewed in detail by Carpenter (2006). 
 In summary, these reviews shed little light on the basic question on whether eating fish is likely to 
improve health and survival, in part because they do not cover the full range of exposure issues.    
 
1.3  Measures of Effect 
Burger et al. (2003) showed that the absolute quantity of Hg in fish is relatively constant during 
frying, but that the concentrations are higher on a dry weight (cooked) basis than for raw fish (wet weight 
basis).  Thus, there may be uncertainties about actual intake doses when based on fish consumption 
frequencies alone. 
Most of the extant epidemiological literature has been concerned with testing hypotheses, as to 
whether or not a specific agent may in fact exhibit the hypothesized effect (yes/no).  For observational 
studies, a common approach has been to divide the observations into equally-sized groups (n-tiles. where n 
is usually from 3 to 6, i.e., tertiles to sextiles).  Many authors then use the most-exposed group to test the 
hypothesis of whether the hypothesized effect exists (i.e., is statistically significant relative to the lowest 
exposure group), essentially ignoring the information implied by the relative risks shown for the 
intermediate n-tile groups.  Also, it may be problematic to compare such findings across groups of studies 
with very different exposure levels.  Since extreme exposures may be required to successfully test these 
“existence” hypotheses, this information may not always be relevant to less-exposed populations or 
situations.  A dose-response relationship across all the n-tiles may thus be more useful, once the hypothesis 
of causality has been accepted (if only tentatively). 
Comparing the observational cohort studies of seafood, MeHg, and PUFA effects requires a way 
to compare the various types of exposures used, which include measured levels in blood or adipose (fat) 
tissue as well as estimates based on diet.  One way around this obstacle is to compare the slopes of dose-
response functions based on logarithmic-transformed (log-log) regression models of relative risks or odds 
ratios across the various n-tiles.  This linearization paradigm ignores the statistical significance levels of 
individual n-tile estimates, which are affected by sample size and the range of exposures, and focuses on 
the relative magnitudes of the effects across the entire range of exposures.  The slope of a log-log model is 
independent of the units of exposure measurement and corresponds to the elasticity metric used by 
economists (Lipfert, 1994).   For example, a log-log slope of 1.0 implies a directly proportional 1:1 
relationship, such that the predictor accounts for all of the variability in the endpoint.   A log-log slope of –
0.10 indicates that for each 10% increase in the predictor variable, the dependent variable decreases by 1%.  
This paradigm is used to compare some of the various dose-response relationships implied by the studies 
considered.  However, complications may arise when a threshold is observed (RRs for intermediate n-tiles 
= ~1.0).   
By way of comparison, Stampfer et al. (2000) present n-tile risk data for the Nurses Health Study 
for some of the major coronary risk factors, which we converted to log-log slopes: body-mass index, 0.88 
(this is an example of a predictor with a definite “background” level); smoking, about 0.31; diet score, -
0.35; exercise, -0.13; and alcohol consumption, -0.074. 
 
1.4  Plan of This Review 
Table 1 depicts a somewhat tautologic outline for the evaluation of evidence relating to this topic, 
including the most general types of epidemiological studies (national death rates vs. national fish 
consumption levels, for example) as well as more specific types of cohort studies in which very detailed 
data on exposures and outcomes are often available.  The table indicates that there are a number of possible 
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reasons for a false indication of “no beneficial effect” but only one general reason for a beneficial 
indication: confounding by correlated lifestyle or dietary factors other than eating fish.  We intend to 
evaluate all of these alternative hypotheses in this review.  Of course, in any epidemiological study, a true 
effect may be obscured by imprecise or inappropriate measurements.  When two or more correlated causal 
factors are considered jointly (for example, Hg and PUFAs), those with the more accurate and precise 
measurements are likely to prevail (Lipfert, 1997).  Thus, exposures based on measured biomarker levels 
would be preferable to those based on estimated dietary intake rates. 
 
 
Table 1   Alternative Hypotheses for Consideration 
 
 
Observation:  “Is Eating Fish Indicated to Improve Health and Survival?” 
 
A.    Yes       B.    No 
 
A1.  Other associated diet or lifestyle factors are responsible.    B1.  Study has insufficient statistical power 
          (examples: eating less red meat, drinking alcohol,     (random variation) 
exercising more) 
 
A2.   Eating fish is truly beneficial    B2.   Fish consumption data are flawed. 
   
 A2a.  because of PUFAs    B3.   Insufficient fish consumption   
 A2b.  because of other fish nutrients 
 A2c.  because other contaminants don’t  matter B4.   Confounding from other factors  
  A2c1.  their concentrations are too low 
  A2c2.  their effects are truly benign.  B5.   Inappropriate health endpoint   
   
A3.  An ecological fallacy is present    B6.   Results are limited to a specific cohort.  
 (ecological studies only)    (because of genetics or pre-existing disease) 
           
B7.   Because of specific types of fish eaten 
 
        B7a.  low PUFA levels 
        B7b.  other fats (fried fish) 
        B7c.  high Hg levels 
        B7d.  other fish contaminants 
        B7e.  harmful ingredients in specific  
           types of fish. 
 
B8.  An ecological fallacy is present      
  (ecological studies only 
 
 
The “ecological fallacy” referred to in Table 1 is a well-known weakness of studies based on 
population groups rather than individuals: although a group-average risk may be associated with risk 
factors averaged across groups, such a relationship may not always apply to individuals within the groups.  
In this paper, we summarize relevant portions of the extant literature and compute some additional 
statistics to facilitate comparisons across studies.  We consider the literature in several categories: 
   
• Studies of (adverse) mercury health effects (Section 2) 
• Studies of (presumably beneficial) effects of fatty acids, mainly n-3 PUFAs (Section 3) 
• Studies of seafood consumption per se, which presumably encompass both types of  
        effects, including ecological studies of national populations (Section 4). 
• Studies of overall diets and dietary interventions (Section 5). 
   
The review emphasizes various cardiovascular end points including mortality, as well as mortality from any 
cause.  The concluding discussion (Section 6) includes the overall implications with respect to the U.S. 
population.  An Appendix defines abbreviations and notations used in the tables and text. 
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2.  Studies of Mercury and Cardiovascular Health Effects 
 
2.1 Definitions and Measurements 
Almost all of the mercury in fish is in the form of methylmercury (MeHg), so that the exceptions 
in this section are identified as elemental or inorganic Hg.  The preferred exposure metrics are Hg in head 
hair (ppm or µg/g) or blood (µg/L), to facilitate comparisons with existing data bases.  The ratio between 
MeHg in hair (ppm) and in blood (µg/L) is about 250. 
Two of the larger studies of acute events (Guallar et al., 2002, Yoshizawa et al. 2002) used toenail 
clippings to estimate exposures instead of the more common head hair metric.  To convert the toenail 
values to a basis of head hair, we rely on two case-control studies of dental workers.  Since such workers 
may be inordinately exposed to inorganic Hg from dental amalgams, we used data on the non-dentist 
“control” subjects in these studies.  Ritchie et al. (2002) report mean toenail clipping and head hair levels of 
0.24 and 0.57µg/g respectively, for a ratio of 0.42.  Morton et al. (2004) report levels of 0.18 and 0.40, for a 
ratio 0f 0.45.  We use the average of these two estimates to convert toenail Hg data to a head-hair basis (0.6 
and 1.0 µg/g for the Guallar and Yoshizawa studies, respectively).  For reference, the median and 95th 
percentile hair Hg levels in the U.S. are about 0.2 and 1.6 ppm, respectively (McDowell et al., 2004).     
 
2.2  The Extant Literature on Cardiovascular Effects of Mercury 
Table 2 summarizes eight epidemiological studies of cardiovascular health effects as a function of 
mercury exposures, seven of which involve European subjects.  The effect estimates shown are “fully 
adjusted” for confounders.  The paper of Ahlqvist et al. (1999) reported only p-values and the signs of 
correlations, which precludes making estimates of the avoided deaths.  The only American study involved 
male health professionals, including dentists.  This group of studies exhibits very mixed results, most of 
which showed non-linear responses, so that higher relative risks (RRs) were often seen at exposures greater 
than the mean values shown in the Table.  The responses also vary by end point; the risks for non-fatal 
cardiac events (denoted with asterisks) tend to be positively associated with mercury exposures (negative 
“avoided” events) while cardiovascular mortality tends to be negatively associated (positive avoided 
deaths).   
Table 2 also provides estimates of the “avoided deaths”, defined as (1-RR )*total deaths for each 
cause; this facilitates consideration of the additional deaths involved in successively broader cause-of-death 
categories.  For example, in the latest paper on the Finnish cohort study (Virtanen et al., 2005), 
cardiovascular causes account for all of the all-cause deaths ascribed to mercury exposure, while this is 
(apparently) not the case for the occupational study of Boffetta et al. (2001).  We then summed these 
incremental death counts across studies and divided by the total deaths to provide weighted-average 
estimates of the mean relative risks (Table 3).  The implications of the small additional risks of all-cause 
mortality and CVD events are unclear but could be the result of random variation (there are too few studies 
to permit meaningful statistical significance tests). 
Boffetta et al. studied mercury mine and mill workers, whose (inorganic Hg) exposures are orders 
of magnitude higher than those of the general public (Kingman et al., 1998). Note the small number of 
hypertension deaths (Hg effects on blood pressure are discussed below) and the absence of significant 
cardiovascular effects in these highly exposed workers.   
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Table 2   Mortality and Cardiovascular Events as a Function of Mercury Exposure (RRs at mean consumption levels) 
 
              mean fish  mean   estimated   avoided        
1st author, yr period location    cause of death   group    # subjects       # events       meals/wk     Hg     mean RR     events           remarks  
Ahlqvist,1999    1974-93  Sweden       all  women        1397 253       n/a        n/a     negative correlation  n/a 
 
Boffetta, 2001    1950-90  Europe         all        Hg workers   7049          2749       n/a      ~300U   1.08+ (1.04-1.12)     -220    not adjusted  
        hypertension        49      1.4 (0.3-6)         -20     for confounders 
        IHD       259      0.9 (0.5-1.6)          26 
        CVD       261      0.7 (0.4-1.4)               78 
        other heart      271      1.1 (0.6-2.0)           -27 
 
Guallar, 2002 1991-2   Europe       acute MI*          males        1408  684       n/a      0.26T   1.18 (0.67-2.07)         -123 
 + Israel        
 
Hallgren, 2001  1985-94  Sweden        acute MI*      volunteers       234   78      ~1.5   ~0.6H     0.91 (0.49-1.69)           7 
 
Rissanen, 2000 1984-97  Finland        acute CHD*    males        1871 194      ~2.0     1.82H      ~1.4          -26  
 
Salonen, 1995  1984-89   Finland        all       males        1833   78       ~2.0    1.92H       1.17 (1.006-1.39)    -13  
     CHD        18        1.44 (1.08-1.92)        -8 
        CVD       24        1.32 (1.03-1.70 )       -8 
 
Virtanen, 2005  1984-98  Finland          all        males         1871 525       ~2.0     1.8H      0.92 (0.71-1.19)        42  
         CHD       91        0.61 (0.34-1.10)        35 
         CVD     132        0.66 (0.41-1.07)        45 
         acute event*    282        1.07 (0.77-1.49)       -20 
 
Yoshizawa,2002 1986-91  all US          CHD cases     male health     33737       470      ~1.3      0.45T       0.83 (0.53-1.30)        22# 
            professionals  
Yoshizawa,2002 1986-91  all US          CHD cases     w/o dentists          220      ~1.3    ~0.33T       1.70 (0.78-3.73)     -154# 
 
 
 
* first-ever heart attacks (not deaths) 
H = hair level, µg/g;  T = toenail level, µg/g; U = urinary level (inorganic Hg), µg/L 
# based on nonlinear relationship 
+ Standardized mortality ratio (Hg exposure data not provided) 
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The study of Guallar et al. includes cohorts from 8 European countries (two from Spain), plus one 
from Jerusalem, Israel (from the EURAMIC study).  The range of estimated individual head hair Hg levels 
was from 0.18 to 1.8 for the controls and 0.21 to 2.5 for heart attack patients.  However, by cohort, only 
one showed significantly higher mean Hg exposures for patients than for controls (Malaga, Spain), which 
also had the highest Hg levels, and the exposures of patients were significantly higher than for controls, by 
15%, after adjustment for confounders. Other EURAMIC papers provide other cohort data, for toenail Se 
(Kardinaal et al., 1997) and fatty acids (Guallar et al., 1999).  Cross-plots of these exposure data by cohort 
(Figure 1a,b,c) show the Spanish Hg data to be outliers (high levels) with respect to the data for Se and for 
fatty acids, all of which presumably derive mainly from eating fish.  Dropping the two Spanish cohorts 
would appear to render the Hg-heart attack relationship non-significant, on the basis of mean cohort levels.  
Both of the Spanish cities are on the Mediterranean Sea; perhaps other dietary components played a role 
(no fish consumption data were provided).  Chan and Egeland (2004) also discuss this aspect of the 
EURAMIC cohort study.  Welch et al. (2002) provide data on fish consumption for 10 European countries 
by type of fish and noted that consumption of fatty fish seems to follow that of total fish.  Intake of fatty 
fish was highest in northern European coastal areas with lean fish predominating in France, Italy, and 
Spain.  
The relative risks for mercury exposures in the Finnish cohort study (Salonen et al., 1995b; 
Rissanen et al., 2000; Virtanen et al., 2005) have decreased over time.  The most recent paper (Virtanen et 
al., in press) is based on ~14 years of follow-up and shows negative mortality effects at the mean exposure 
levels (middle tertile), but stronger positive effects at the highest exposure levels, yielding an overall 
adverse effect of mercury exposure.    
It is perhaps unfortunate that the only U.S. study included a high proportion of dentists (~50%); 
Yoshizawa et al. reported that when the dentists were excluded from the analysis, the risk of CHD 
associated with Hg exposure (presumably from fish) was positive but not significant (median risk level not 
reported).  Also, the results of Yoshizawa et al. imply that controlling the Hg analysis for PUFA intake 
tends to slightly increase the estimated Hg risks.  Excluding the dentists from the RR summary above 
would have resulted in a stronger adverse effect of Hg exposure on non-fatal CHD risks.  This finding, 
together with the results of Bofetta et al. suggests major differences in the cardiovascular effects of organic 
(MeHg) and inorganic mercury exposures. 
In summary, the main evidence for adverse effects of MeHg exposure on cardiovascular health comes from 
the Finnish cohort studies, which suggest a hair Hg threshold of about 2 ppm. 
 
 
 
Table 3 Mean Relative Cardiovascular and Mortality Risks from Mercury 
(Based on Table 2) 
 
Cause of Death     Avoided deaths/ 
      Total deaths 
Avg Relative  
Risk 
All causes (3 studies) -101/3352 1.06 
CHD, IHD mortality (3 studies) 53/368 0.86 
CVD mortality (3 studies) 115/417 0.72 
CVD events or cases (5 studies) -140/1748 1.08 
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Figure 1  Biomarker data from the EURAMIC study by cohort, for cases and controls.  (a)  Toenail Se. vs. 
toenail Hg.  (b)  Adipose DHA vs. toenail Hg.  (c)  Adipose ALA vs. toenail Hg. 
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2.3 Other Health Effects of Methylmercury 
The literature includes epidemiological studies of health endpoints other than mortality, some of 
which are briefly summarized in this section.  However, since the extant neurological studies are well-
known, only recent papers on that topic have been included.  
 
2.3.1    Blood Pressure.  Blood pressure effects have been examined in several papers.  An early study of 
dietary fats (Margolin et al., 1991) showed that dietary supplements of both fish oil and corn oil reduced 
blood pressure significantly after 8 weeks of treatment in elderly hypertensive patients.  However, Morris et 
al. (1993) found no significant effect of fish oil on 18 healthy subjects, as did Rasmussen et al. (2006) in a 
larger study of 162 subjects.  A subsequent meta-analysis (Morris et al., 1993) confirmed that blood 
pressure reduction by fish oil is strongest in subjects with hypertension or coronary heart disease.   
Vupputuri et al. (2005) linked NHANES mercury exposure data with blood pressure in 1240 U.S. 
women, by fish consumption.  There were no relationships with diastolic blood pressure, but systolic 
pressure increased significantly with blood Hg for non-fisheaters and decreased (non-significantly) for fish 
consumers, with no overall association.  Fish consumption per se was controlled for in the analysis of fish 
eaters.  The authors concluded that their findings support the hypothesis that fish oils may counter the 
harmful effects of mercury.  In this sample, 97% of the inorganic Hg samples were below the detection 
limit, which leaves open the question of differences between Hg compounds. 
 Pedersen et al. (2005) compared blood pressure and blood mercury levels in Greenlanders and 
Danes (n=198), over a much wider range of mercury exposures.  The most consistent finding was that of a 
significant increase in pulse pressure (systolic less diastolic pressures) with increased blood mercury.  
However, Jorgensen et al. (2002) had concluded that a portion of this increase could have been due to 
genetic factors.  The rate of increase was about the same as that reported by Vupputuri et al. for systolic 
pressure, which amounts to a mean blood pressure effect for the U.S. population of only a few mmHg.  
Pulse pressure is regarded as an indicator of arterial stiffness (de la Sierra, 2006). 
 Blood pressure data were obtained from native peoples in the Amazon rain forest, where fish is an 
important part of the diet (Dorea et al., 2005).  Average hair Hg (2.5 to 12.8 ppm) increased with mean fish 
consumption (22 to 110 g/d), but there were no neurological indications of Hg poisoning.  For the total 
group, hair Hg was not significantly associated with increased blood pressure, but the high Hg exposure 
group had a stronger blood pressure increase with age.  The authors concluded that access to medical care 
was far more important for these populations than any effects from mercury in fish. 
 Barberger-Gateau (2005) reported that elderly “regular” (at least weekly) fish eaters in France 
were more likely to suffer from hypertension, but blood pressure data were not provided. 
 Sorensen et al. (1999) reported that both diastolic and systolic pressures increased with Hg 
exposures in 7-y old Faroese children who had been exposed prenatally, but only at the low end of the 
exposure scale.  There was no effect above about 2 ppm maternal hair concentration; this might be another 
manifestation of interaction between Hg and PUFA, since the most highly exposed Faroese also consume 
fatty marine mammals.  Grandjean et al. (2004) examined these children at age 14 and concluded that there 
was “no discernible effect” on blood pressure. 
 In summary, the evidence for increased blood pressure due to fish consumption is scant.  No study 
has controlled for all of relevant dietary variables (such as red meat, for example).  Any such adverse 
effects of Hg in the U.S. population are likely to be small and of doubtful clinical importance. 
 
2.3.2   Autonomic Control.  Reduced heart rate variability (HRV) is another indicator of potential 
cardiovascular risk.  Grandjean et al. (2004) found decreases associated with prenatal Hg exposures in 14-y 
old Faroese children.  Oka et al. (2002) examined blood pressure and HRV in 9 patients who had been 
diagnosed with fetal type Minamata disease, which involved very high exposures to MeHg, but probably 
normal levels of PUFA.  They found indications of reduced HRV but also lower pulse blood pressure.  
Christensen (2003) reports a positive correlation between HRV and PUFA and also increases in HRV in 
response to supplemental PUFA.  Murata et al. (2006) examined the effects of prenatal exposure to MeHg 
in 136 Japanese schoolchildren, age 7.  Umbilical cord tissue MeHg was significantly associated with 
decreased HRV while current hair Hg was not.  The authors concluded that postnatal exposures less than 4 
ppm MeHg in hair may not influence cardiac autonomic function. 
 The effect of fish consumption on heart rate was examined by Dallongeville et al. (2003) in 9758 
men from France and Northern Ireland.  A highly significant negative association was found, after 
confounder control, with an average slope of –0.75 beats/min per weekly fish meal. However, according to 
 10
the Paris mortality data of Jouven et al. (1999), such a small effect corresponds to a decreased risk of 
sudden death of about 1% and of fatal heart attack, about 1.5%.  Given the much larger relative risks seen 
in Table 2, there must be factors other than heart rate involved.  Mozaffarian et al. (2006) also found that 
heart rate decreased with consumption of (non-fried) fish, with a slope of –0.5 beats/min per weekly fish 
meal, even though there was slightly higher prevalence of CHD among frequent fish eaters.  Other 
electrocardiographic parameters were also reported to vary with fish consumption, some of which are 
consistent with improved survival. 
 Romieu et al. (2005) examined the effect of fish oil supplements on HRV responses to ambient 
PM2.5 air pollution in Mexico City, for 50 elderly nursing home residents.  Fish oil was contrasted with soy 
oil; both were found to be significant attenuators of air pollution effects on HRV, with fish oil somewhat 
better than soy oil.  These findings suggest interactions between dietary and inhalation exposure pathways. 
 Taken together, these studies do not support adverse effects of either fish consumption or modest 
levels of Hg exposure on cardiac autonomic control. 
  
2.3.3  Mercury and Development of Atherosclerosis.  Salonen et al. (2000) measured carotid artery 
intima-media thickness in 1014 Finnish males and found a relationship with hair Hg levels in the range 2.8 
- 23 ppm (but not below this level).  This suggests that Hg accumulation may be associated with 
accelerated progression of atherosclerosis.  By contrast, Erkkila et al. found that higher levels of fish intake 
(2004) and plasma DHA (2006, in press) were associated with less progression of atherosclerosis in 
postmenopausal women.  Also, Sacks et al. (1995) reported no effect of fish oil supplementation for 2 y 
arterial narrowing, in spite of higher adipose EPA levels in the treatment group/  
 
2.3.4   Recent Papers on Neurobehavioral Function.   Debes et al. (2006) reported on the 14-y follow-up 
of the Faroese children, in which neurological responses were deemed to be consistent with previous 
evaluations where some effects were found.  (The median exposure level is about 16 µg/L as maternal 
blood Hg.)  This may imply extension of these effects into adulthood.   
 By contrast, Davidson et al. (2006) performed a longitudinal analysis of repeated IQ evaluations of 
individual Seychelles children and found no significant associations with prenatal exposures to MeHg.  
Their consumption of ocean fish is an order of magnitude higher than typical levels in the United States. 
 A new birth cohort study of 599 pregnant women has begun to produce results in Japan (Nakai et 
al., 2004; Suzuki et al., 2006).  Among several developmental tests, infants showed adverse effects 
associated with maternal hair Hg levels (mean=2.2 ppm) but beneficial effects associated with maternal fish 
consumption (mean=69 g/d).  Data on PCB exposures were also collected but have not yet been analyzed. 
Weil et al. (2005) studied a random cohort of adults in Baltimore, whose median blood Hg level 
was 2.1 µg/L, which is at about the 80th percentile of the NHANES survey child-bearing aged U.S. women 
(Jones et al., 2004).  Neurological test results for the Baltimore cohort were mixed, and the authors 
concluded that their results “do not provide strong evidence that blood mercury levels are associated with 
worse neurobehavioral performance...”.  These results could then be viewed as also implying the absence of 
effects of childhood/prenatal exposures. 
Daniels et al. (2004) examined a cohort of 7421 British children, comparing two measures of 
neurodevelopment (at 15 and 18 months of age) against fish consumption and umbilical cord tissue 
concentrations of total Hg (in a subset of 1054 children).  They concluded that total Hg concentrations were 
low and not associated with neurodevelopment and that moderate fish intake is associated with increased 
development.  However, the umbilical cord Hg levels were about half of those seen in the Faroes 
(Grandjean et al., 2005), and thus are not “low” in the context of the U.S. population.  
Jedrychowski et al. (2006) examined the blood mercury levels of nonsmoking mothers of 233 
Polish 1-y old infants and found a significantly lower mean level in mothers of normal infants relative to 
mothers of infants with delayed neurocognitive performance.  However, the analysis seems to focus on the 
mean exposure differences between the 197 infants with “normal” performance” and the 36 infants with 
“delayed” performance, and it is not clear if or how confounders such as maternal age (higher in the 
“delayed” group) or birth weight (lower in the “delayed” group) may have been controlled.  The amounts 
of developmental delay were not discussed.  
Blood Hg levels in this Polish cohort are low (0.5-0.8 µg/L).  A review of the worldwide literature 
on “normal” levels (without occupational exposure) reported a mean blood Hg level of 2.0 µg/L based on 
six studies of non-fisheaters, increasing to 4.8, 8.4, and 44.4 µg/L for those consuming <2, 2-4, and >4 fish 
meals per week (up to 10 studies), respectively (Brune et al., 1991). For U.S. women of childbearing age, 
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the 1999-2000 median blood Hg levels with and without fish consumption are 0.8 and 2.3 µg/L, 
respectively (Vuppituri et al., 2005).  This suggests that agents other than MeHg may have been involved in 
the Polish study.  
 The question of linkage between Hg exposure and adult dementia has been debated for some time.  
Originally, the primary suspect was inorganic Hg, in relation to dental amalgam, for example  (Schurrs and 
de Wolff, 1997; Saxe et al., 1999; Ely, 2001; Mutter et al., 2004; Mutter and Nauman, 2005).  With respect 
to possible contributions from MeHg, Morris et al. (2003) followed 815 elderly subjects for four years and 
found that the risk of developing Alzheimer’s disease was 60% less in those who ate fish at least once per 
week, after adjusting for confounders.  Engelhart et al. (2002) found no significant effects of various types 
of dietary fats (including n-3 PUFAs) on the risk of dementia, while Kalmijn et al. (2004) found that, 
among 1613 middle-aged subjects, fatty fish and the associated PUFAs were associated with decreased 
risks and cholesterol and saturated fats were associated with increased risk of impaired cognitive function.  
Barberger-Gateau (2002) also found a significant decrease in the incidence of dementia among 17674 
elderly French subjects who ate fish or seafood weekly.  Thus, it appears to be important to distinguish 
between inorganic Hg and MeHg exposures with regard to cognitive effects in adults. 
 In summary, a wide range of responses still characterizes the effects of prenatal exposures to 
MeHg, which seem to be stable over time in the affected children.  However, there is no credible evidence 
for neurological effects of MeHg on adults. 
 
3.   Health Effects of Polyunsaturated Fatty Acids (PUFAs) 
 
3.1  Introduction 
The literature on PUFAs is quite extensive and will not be discussed in detail here (about 7000 entries 
in MEDLINE for omega-3 fatty acids).  It includes observational studies in which PUFA intake is 
estimated based on consumption frequencies of foods containing PUFAs, intervention studies in which 
either fatty-fish diets or fish-oil supplements are instituted, and studies of PUFAs as therapy for cardiac 
victims.  Although the totality of all studies is not unanimous in finding benefits, the weight of evidence 
was sufficiently convincing that the American Heart Association (Kris-Etherton et al., 2003) recommended 
a daily diet that contains 650 mg of PUFAs, which is considerably higher than the current level of 100-150 
mg/d (Holub and Holub, 2004). 
 PUFAs have been associated with the following health effects: 
 
• reduced likelihood of diabetes (Haag and Dippenaar (2005). 
• a small mean increase (0.13 points) in child IQ (Cohen et al., 2005). 
• triglycerides, cholesterol, platelets, inflammation, oxidative stress (Mori and Beilin, 2004).  
• increased heart rate variability (Holguin et al., 2005; Christensen, 2003). 
• reduced heart rate (Dallongeville et al., 2003; Mozaffarian et al., 2006). 
• large reductions in the risk of sudden death (Albert et al., 2002; Marchioli et al., 2002). 
• reduced mortality from various causes (Dolecek, 1992). 
• reduced risk of nonfatal heart attack (Tavani et al., 2001; Lemaitre et al., 2003). 
• reduced risk of fatal ischemic heart disease (Lemaitre et al., 2003). 
• reduced risk of adult dementia (Engelhart, 2002; Kalmijn et al., 2004. 
 
Other effects inferred from fish consumption include: 
 
• reduced development of allergic diseases in childhood (Kull et al., 2006). 
• reduced progression of atherosclerosis (Erkkila et al., 2004). 
 
However, no significant effects of fish oil on ventricular tachyarrythmias and death were reported by 
Brouwer et al. (2006).  Burr et al. (2003) reported that 3114 male angina patients showed no benefits from 
dietary intervention, including either fish or fish-oil capsules; the group given the capsules showed an 
increase in cardiac deaths.  In the same research group, Ness et al. (2002) reported that, among 2033 men 
who had survived a previous heart attack, short-term (< 2 y) benefits from eating more fish were shown, 
but there was no significant long-term benefit (adjusted RR = 0.95 [0.85-1.07]. 
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3.2  Definitions, Exposure, and Effect Estimates.  
The “marine” PUFA fatty acid compounds referred to as long-chain omega-3 (n-3) include 
eicosapentaenoic (EPA), docosahexaenoic (DHA), and docasapentaenoic (DPA) acids, extracts of which 
are often called “fish oil” and are commercially available as dietary supplements.  A non-marine n-3 fatty 
acid, α-linolenic acid, derives from vegetable oils and is an essential nutrient.  Vegetable oils (corn, 
sunflower, soybean, and safflower oils) are enriched in omega-6 (n-6) fatty acid, known as lineolic acid, 
which has generally shown lesser cardiovascular benefits (Holub and Holub, 2004).   
 Most of the extant studies have synthesized their exposure estimates, based on food frequency data 
and the PUFA contents of typical foods.  Others have measured PUFA levels directly, either in blood or in 
adipose tissue samples.  Because of potential differences in metabolic processes, it would appear that the 
measured PUFA data would be more accurate and thus to be preferred.  For randomized control trials 
(RCTs) of supplemental fish oils, the putative doses are known, but the degree of subject compliance with 
the intervention regimen during long trials may be an issue.  
 The available exposure data show a potentially important difference between exposures based on 
intake estimates and those based on biomarkers.  The intake estimates are basically analogues of food 
(especially fish) consumption, such that the exposure of the reference or control group is essentially nil.  
This is also the situation with respect to RCTs of supplemental doses.  However, biomarker data usually 
show appreciable (background?) levels of PUFAs for these reference or control groups (Welch et al., in 
press; Siscovick et al., 2000; Pedersen et al., 2000).  Thus, questions arise as to whether the relative 
magnitudes of these background levels might be important and whether they in fact constitute thresholds.  
In the latter scenario, PUFA levels below the putative threshold could result in failure to find health 
benefits of fish consumption or supplemental fish oils.  This hypothesis is supported by the findings of 
Wallace et al. (2003) of a threshold in the effect of EPA+DHA intake on decreased interleukin-6 
production, of Fernandez-Jarne et al. (2002) and a threshold in the relationship between fish intake and 
heart attacks, and of the conclusion of Alonzo et al. (2003) that the epidemiological literature suggests 
threshold effects. 
  
3.3 Observational Epidemiology Studies.   
The Multiple Risk Factor Intervention Trial (MRFIT) analyzed the effects of various types of PUFAs 
in detail with respect to mortality from various causes in the control group (no intervention) of white 
middle-aged men at high risk of developing CHD (Dolecek, 1992; Dolecek and Grandits, 1991).  The most 
consistent mortality benefits were seen with marine (n-3) PUFA compounds, which comprised only a small 
portion of the total PUFA intake (175 mg/d).  Only the quintile with the highest intake (664 mg/d) showed 
significant mortality benefits, for all causes, CHD, and CVD (but not for cancer), suggesting a threshold 
effect.  No data were provided on rates of fish consumption.  As discussed above, meta-analyses of RCTs 
of PUFAs are sensitive to the inclusion of specific studies and to the selection of health endpoints.  A more 
approximate but broad-based estimate of the MRFIT results may be estimated by considering the effects of 
the intervention group, whose coronary heart disease mortality decreased by 10.6% after 10.5 years of 
follow-up (MRFIT Research Group, 1990), while their intakes of PUFA increased by 33% (Gorder et al., 
1986).  This leads to an estimated elasticity of -0.105/0.33 = -0.32.  Gorder et al. also indicated increased 
consumption of fish.  
 The EURAMIC study (discussed above with respect to Hg) also examined the effects of fatty 
acids on heart attack risk, based on adipose tissue samples.  No protective effects were found; it was also 
noted that EPA levels were below the detection limit for most samples.  Perhaps this indicates that marine 
PUFA levels were too low to register an effect (i.e., below the threshold).   Also, the paper by Ascherio et 
al. (1995) involved the same cohort as that of Yoshizawa et al., 2002 (see Table 2), and it appears that the 
mean intake of fatty acids may be in the low end of the range.  
Table 4 compares log-log slope estimates for selected observational cohort studies involving 
various (n-3) PUFAs.  Some studies provided data on relative risks by n-tiles of fish consumption as well as 
by fatty acid level; comparing these regression slopes provides some insights as to which predictor fits the 
data better (for this specific modeling paradigm).  If fish consumption data were to fit better, for example, 
we would conclude that fatty acids were serving as a surrogate agent for some other fish constituent.  If the 
slope for fish consumption were substantially lower than that for fatty acids, we might conclude that fish 
consumption data also encapsulated a harmful agent such as MeHg, for example.  The table is organized to 
show RRs based on measured PUFAs first (Table 4A), with blood data followed by adipose (fat) tissue 
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data.  Table 4B presents the results based on PUFA intake levels, as estimated from specific food 
consumption frequencies. 
 The first impression from Table 4 is that almost all of the slopes are negative, indicating beneficial 
effects; the results of Pietinen et al. (Finland) are an important exception.  This was a larger cohort than in 
the KIHD, and none of the RRs for “omega-3 fish fatty acids” were statistically significant, based on 
estimated daily intake rates.  No data were presented on fish contaminants or on the species consumed. 
 The next impression is that the slopes of RR vs. PUFA levels are consistently stronger (more 
negative) than those based on fish consumption alone.  This is the case in 14 of the 16 comparisons, and the 
two exceptions are based on intake estimates.  Finally, the slopes based on measured PUFA levels tend to 
be stronger (more negative) than those based on estimated intake rates.  This is the case even when baseline 
PUFA thresholds are assumed for the slope calculation.  The correlations between intake rates and 
biomarker concentrations tend to be significant but modest, in the range 0.4-0.6 (Andersen et al., 1996; 
Kobayashi et al., 2003).  If we assume that the biomarker data are the “true” indicators, then we would 
expect the slopes based on intake rates to be around half of the values found with biomarkers.  We would 
also expect fewer statistically significant relationships based on intake rates, for a given sample size. 
 It is also interesting to note that the EURAMIC data of Guallar et al. (1999) showed very weak, 
nonsignificant responses to PUFA, for which (measured) concentration levels are quite low in comparison 
to the other studies.  This is the same cohort that showed adverse CVD effects associated with toenail 
concentrations of Hg.    
 Figure 2 is a plot of relative mortality risks as a function of n-3 PUFA concentrations measured in 
blood, as the percentage of all fatty acids.  Data from the studies of Albert et al. (2002), Siscovick et al. 
(2000), Pedersen et al. (2000), and Daviglus (1997) represent relative risks by n-tile of fatty acid level, 
taken directly from the publications.  Results from the Finnish study of Virtanen et al. that combined Hg 
and PUFA data are based on the mean PUFA levels for each Hg tertile (as opposed to PUFA tertiles).  The 
linear RR regression coefficients given in the paper for DHA and DPA (only) and for the subset of subjects 
with hair Hg < 2 ppm were then used to estimate the trend in PUFA effects.  The general trends of these 
plots are consistent with reports of very low incidence of heart disease among the Arctic Inuit peoples and 
an average EPA+DPA value of about 7% (DeWailly et al., 2001).  The plot is also consistent with the 
failure of Guallar et al. (1995) to find significant effects at relatively low levels of PUFAs. 
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Figure 2  Results of cohort studies of mortality vs. the percentage of n-3 fatty acids in blood.  Each study 
normalized to a relative risk of 1 at the lowest n-3 fatty acid level in that study. 
 
Although there are substantial variations among the studies shown in Figure 2, the overall 
impression is one of an effect threshold at PUFA levels of about 3-5% of total fatty acids.  This is also 
consistent with the results of Lemaitre et al. (2003), who showed levels of 3.3% and 3.8%  DHA+EPA for 
fatal IHD cases and controls, respectively (not included in Table 4).  This suggests that dietary supplements 
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of PUFAs may be more effective in populations whose mean baseline levels exceed the threshold.  In the 
absence of PUFA n-tile data for the Finnish cohort, we can only speculate whether their PUFA levels might 
be below such a threshold.  This is also the case with the study of Guallar et al., for which EPA data were 
not available. 
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Table 4A   Results from Cohort Studies of Measured PUFA Effects on Cardiovascular Health 
 
1st author period  location    # subjects      agent(s) mean  level endpoint   log-log slope   remarks 
       cases,controls          
Albert, 2002 1982-99   all US       94, 184          n-3 PUFA    4.8%  sudden death -2.6 (no threshold) 
           -0.4 to –0.9 w/thresh   
 
Daviglus, 1997     1957-87   Chicago   1822 men       fish   19 g/d  MI  -0.13 
      PUFA       3.9%  MI  -0.45  (threshold) 
fish   19 g/d  CHD  -0.10 
      PUFA       3.9%  CHD  -0.35  (threshold) 
fish   19 g/d  CVD  -0.065 
      PUFA       3.9%  CVD  -0.22  (threshold) 
fish   19 g/d  any death -0.031 
      PUFA       3.9%  any death -0.11  (threshold) 
 
Erkkila, 2003 1995-00     Finland         415 fish    60 g/d  any death -0.22 
      EPA    1.72%  any death -1.0 
      DHA    0.69%  any death -2.0 
fish      60 g/d  CAD death  0.05 
      EPA    1.72%  CAD death -1.1 
      DHA    0.69%  CAD death -1.2 
 
Guallar, 1995 1984-89   all US       14916 men     EPA    0.49%  heart attack -0.03     not signficant  
          (physicians) DHA    2.11%  heart attack  0.11     not signficant 
      EPA+DHA  2.6%  heart attack  0.31     not signficant 
 
Rissanen, 2000    1984-97   Finland        1871 men n-3 PUFA     2.9% CHD event          -0.74  
      hair Hg       1.9 ppm CHD event  0.44 joint regression 
 
Virtanen, 2005 1984-98    Finland        1249 men  n-3 PUFA      3.0%  any death -0.11 
      (hair Hg <2.0 ppm) CHD death -0.84 
         1871 men   n-3 PUFA      3.0%  any death -0.12 
      (hair Hg = 1.9 ppm) CHD death -0.54 
 
Siscovick, 2000    1988-94   Seattle         334, 493  n-3 PUFA     0.14 g/d  cardiac arrest -0.2  
      n-3 PUFA     4.9% cardiac arrest -4.4   no threshold 
      n-3 PUFA     1.9% cardiac arrest -1.1   thresh = 3% 
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Guallar, 1999        1991-2     Europe       639, 700 ALA        0.8% 1st MI  -0.18   (estimated quintiles)  
      + Israel  DHA        0.25% 1st MI  -0.07   
      (adipose) 
 
Pedersen, 2000    1996   Norway       100, 98 n-3 PUFA    0.68% 1st MI  -1.3 threshold at 0.7% 
      (adipose)   
 
 
 
Table 4B   Results from Cohort Studies of Estimated PUFA Effects on Cardiovascular Health 
 
1st author period  location    # subjects      agent(s) mean  level endpoint   log-log slope   remarks 
       cases,controls          
 
Ascherio, 1995 1986-92   all US     44895 men fish    2.2 m/wk fatal CHD -0.052 
      n-3 PUFA  0.24 g/d fatal CHD -0.005 
fish    2.2 m/wk any CHD -0.007 
      n-3 PUFA  0.24 g/d any CHD  0.043 
 
Dolecek, 1991 1978-85   all US        6250 men fish oils     0.05 g/d CHD death -0.047 
      fish oils     0.05 g/d CVD death -0.046 
      fish oils     0.05 g/d any death -0.029 
 
Iso, 2006 1990-01     Japan       41578 fish     78 g/d  CHD cases -0.16 
      n-3 PUFA   0.9 g/d CHD cases -0.23 
fish     78 g/d  non fatal  -0.35 
      n-3 PUFA   0.9 g/d non fatal  -0.52 
 
Jarvinen, 2006 1970-92    Finland       5220 fish      28 g/d CHD death -0.04 
      n-3 PUFA  0.33 g/d CHD death -0.001 
 
Pietinen, 1997 1988-93    Finland       1399 men n-3 PUFA     0.4 g/d CHD event  0.11 
      n-3 PUFA     0.4 g/d CHD deaths  0.17 
 
Tavani, 2001 1995-9     Milan         507, 478    n-3 PUFA     ~0.14 g/d nonfatal MI -0.45 
            fish        ~1.5 m/wk nonfatal MI -0.21 
 
Yuan,  2001 1986-98   Shanghai      18244 men  fish meals      ~1 m/wk any death -0.083 
      n-3 PUFA     0.08 g/d fatal MI  -0.28 
n-3 PUFA     0.08 g/d IHD death -0.08 
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 In Table 4, only Rissanen et al. (2000) considered the effects of PUFA and Hg separately, but not 
simultaneously.  In order to estimate the combined effect, we regressed these quintile results jointly and 
found significant negative effects of PUFA in conjunction with positive effects of Hg.  This finding needs 
to be corroborated with modeling of individual exposures to both agents as continuous variables. 
 In Table 4B, there is no apparent relationship between mean PUFA intake rates and the log-log 
slopes.  However, the mean intake rates are often much higher than the medians shown in the table.   
In summary, Table 4 shows that observational cohort studies based on measured PUFA biomarker 
levels provide clear evidence of the beneficial effects of these compounds.  Failure to find such effects 
based on intake rates may well be the result of either imprecise estimates or individual variability in terms 
of metabolic processing. 
 
 3.3 Controlled Clinical Trials of Dietary Supplements 
Studies involving dietary supplements of fish oils avoid the complications of fish contaminants 
(Kris-Etherton et al., 2003) and possible life-style differences that may accompany fish consumption.  In 
2002, Bucher et al. published a meta-analysis of 11 randomized controlled trials (RCTs) in which diets of 
7951 patients were enriched with supplemental n-3 PUFAs and the risks of coronary heart disease 
outcomes were compared with those of 7855 unsupplemented patients in control groups.  The n-3 PUFA 
supplemented patients had 20% fewer non-fatal heart attacks, 30% fewer fatal heart attacks, 30% fewer 
sudden deaths, and 20% fewer deaths overall; all of these results were statistically significant.  More 
recently, Hooper et al. (2006) performed a more formal systematic review and meta-analysis that included 
many more studies and participants but that was limited to more broadly defined cardiovascular outcomes 
(total mortality and all cardiovascular events).  Hooper et al. concluded that supplemental n-3 PUFAs 
provided no clear mortality or cardiovascular benefits; the RRs for total mortality and cardiovascular events 
were 0.87 (0.73-1.03) and 0.95 (0.82-1.12), respectively.  No results were provided specifically for heart 
attacks or sudden deaths, and cohort studies showed significant benefits for mortality but not for events.  
Another difference between these two meta-analyses is the inclusion in the latter analysis of a large RCT 
for 3114 angina patients (Burr et al., 2003) that showed some adverse effects from supplemental fish-oil 
capsules.  An earlier evaluation of this cohort (Burr et al., 1989) found beneficial effects.  When Hooper et 
al. removed the Burr et al (2003) study from their data base, the relative risk of all-cause mortality agreed 
with that of Bucher et al. (RR=0.83 [0.75-0.91]).  This illustrates the sensitivity of meta-analysis to the 
criteria used for study inclusion and perhaps the folly of relying too heavily on statistical significance 
criteria.  Bucher et al.’s review was updated by Studer et al. (2005), who presented meta-analysis results 
with and without the Burr paper, which they found to be the main source of heterogeneity among the 14 
RCTs of n-3 fatty acids.  However, the effect on total mortality was about the same: 0.77 (0.63-0.94) vs. 
0.80 (0.69-0.92). Wang et al. (2006), who cite neither Bucher et al nor Hooper et al. (Hooper et al cite an 
earlier version of Wang et al.), also present a systematic review of dietary fatty acids and selected 46 
studies on CVD outcomes for detailed review.  They did not perform meta-analysis, but concluded that n-3 
PUFAs from fish or fish oil reduce all-cause, cardiac, sudden death, and possibly stroke mortality.    
The modest correlations between PUFA intake rates and the corresponding biomarker 
concentrations imply that individuals may vary in terms of their metabolic processing of dietary 
supplements.  This in turn suggests that intervention studies involving supplements should evaluate their 
relative outcomes in terms of biomarker levels as well as in terms of intake rates. 
 Finally, omega-3 fatty acids have been recommended to primary care physicians for cardiac 
therapy (Oh, 2005). 
 
4.  Studies of Mortality vs. Fish Consumption  
 
4.1   Definitions and Measurements 
We define “seafood” or “fish” as including both finfish and shellfish, from either marine or 
freshwater sources, unless otherwise specified.  In converting from meals per week to g/d, we assume an 
average meal size of 150 g for males and 120 g for females.  Where only ranges of consumption are given 
(e.g., 1-2 meals/wk) we assume that the midpoint of the range (e.g., 1.5 meals/wk) represents the entire 
category.  Where open-ended ranges are given, say > 5 meals/wk, we assume an arbitrary value for this 
purpose and test the sensitivity of the result to this assumption. 
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4.2 The Extant Literature.   
 
4.2.1  Cohort Studies.  From the standpoint of risk analysis, the ultimate health endpoint is that of dietary 
effects on all-cause mortality (“any death”).  Although effects on specific causes of death are also of great 
interest, for example, in hypothesizing mechanisms, there may also be misclassification problems and 
competing risks to consider.  Such statistics reflect both direct and indirect effects, including those of 
confounders that might be associated with a seafood-consuming lifestyle.  If the benefits of fatty acids 
outweigh the risks of MeHg, eating more fish should reduce mortality, in the absence of confounding 
effects.  
Table 5 summarizes the results of ten published studies that reported mortality risks as a function 
of fish consumption, for various causes of death.  Most of them presented their results in terms of quintiles 
of exposure, relative to the lowest exposure group.  Table 5 presents the risks for the third quintile, which 
are taken to represent the mean or median risks for the entire cohort (this is tantamount to assuming a linear 
dose-response relationship).  There is considerable diversity among these 21 results; however, all but three 
of them are negative (RR < 1), indicating overall survival benefits from eating fish.  However, only three of 
them are statistically significant, in part because of small sample sizes.   
Table 5 also provides estimates of the “avoided deaths”, defined above. For example, in the 
Western Electric (Daviglus, 1997) and Iowa (Folsom, 2004) studies, there are no additional all-cause deaths 
ascribed to fish consumption relative to cardiovascular causes, while this is (apparently) not the case for the 
studies of Albert (1998) or Nakamura (2005).  As in Table 3, these incremental death counts are summed 
across studies and divided by the total deaths to provide weighted-average estimates of the overall mean 
relative risks (Table 6).   
Note that these estimates are based on different studies for each of these cause-of-death groupings.  
These cohorts are mostly male, and four of the studies are based on health professionals, who may not be 
representative of the general population.  The study of Morris et al, which was superceded by that of Albert 
et al., is included for completeness, but was not used in estimating the overall relative risks listed above.  
The weighted-average RRs above are compatible with the hypothesis that only cardiovascular mortality is 
affected by eating fish. 
The CHD and CVD mortality estimates are reasonably consistent with those in Table 3, even 
though there are far fewer deaths or events with Hg exposure measurements in Table 3.   Such agreement 
implies equivalence between fish consumption and MeHg exposure, i.e., that considering MeHg exposure 
provides no additional information (at mean levels of exposure). 
Table 5 shows only one result for sudden deaths (Albert et al., 1998), for which a 50% reduction 
in risk was reported.  However, reductions in the risk of sudden death have been shown in intervention 
studies featuring dietary fish oil supplements.  Note that the cohort studied by Albert et al. had relatively 
fewer sudden deaths relative to heart attacks, compared too much of the literature on cardiovascular risks.  
This might reflect the higher rates of average fish consumption in this cohort, relative to the U.S. general 
public.   The implied findings of reduced mortality associated with fish consumption for causes of death 
other than cardiovascular imply that other lifestyle effects may be present.  For example, Kromhout (1998) 
pointed out that the non-fish-eating reference group in the Physicians Health Study also smoked more, 
drank less, and exercised less than the fish-eaters and that residual confounding may have been present, 
even though attempts were made to control for these factors.  
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Table 5   Mortality as a Function of Fish Consumption (RRs at mean consumption levels) 
              mean fish     estimated avoided      
1st author, yr period location    cause of death   group    # subjects # deaths    meals/wk    mean RR   deaths        
Albert, 1998 1984-95   all US    sudden death  male Drs.   20551   133       2.5  0.51 (0.25-1.04)       65      
       heart attack      737     1.03 (0.67-1.58)        -22 
       all causes    1652   0.70 (0.54-0.89)       496 
 
Ascherio, 1995 1986-92   all US    CHD          male health      44895               264      2.2  0.71 (0.41-1.21)      77 
               professionals   
 
Daviglus, 1997 1957-83  Chicago  heart attack        males      1822    293      1.0  0.76 (0.52-1.12)      70   
        all CHD     430   0.84 (0.61-1.17)      69 
        all CVD     573   0.89 (0.67-1.19)        63 
    all causes    1042       0.98 (0.79-1.22)        21 
 
Folsom, 2004 1986-97  Iowa    all causes females     41836  4653      2.1  0.93 (0.83-1.05)      326 
       CVD     1589    0.79 (0.63-0.99)      334 
       CHD      922   0.75 (0.55-1.03)    230 
       stroke      313   0.90 (0.53-1.53)        31 
     
He, 2002 1986-98  all US     stroke  male Drs.   43671   608      1.9  0.67 (0.46-0.96)    201  
 
Kromhout, 1985   1960-80  Neth.     CHD  males         852    78      1.0  0.56 (0.27-1.15)        34 
 
Kromhout, 1995   1971-88  Neth.    all  age 65+         272  187      0.5  0.96 (0.72-1.30)        7 
       CHD       58   0.51 (0.29-0.89)      28 
 
(Morris, 1995 1983-8   all US     CVD  male Drs.   21185   121      1.9  1.7 (0.9-3.4)     -85   
  
Nakamura, 2005  1980-99  Japan   all causes random       8879              1745      4.5  0.88 (0.76-1.0)        209 
        stroke      288   0.81 (0.58-1.14)        55 
        CHD     124   0.73 (0.45-1.20)        33 
 
Oomen, 2000  1970-90  Finland    CHD  males       1088  242    ~1.0  0.97 (0.68-1.38)          7 
      Italy        CHD  males       1097  116   0.93 (0.53-1.63)          8 
      Neth.      CHD  males         553  105   1.00 (0.59-1.68)          0 
 
Yuan, 2001 1986-9     China     heart attack males    18244  113     ~2.0  0.72 (0.42-1.21)      32   
       other IHD      74     (fish only)  0.84 (0.40-1.77)      12 
       stroke       480    0.87 (0.65-1.15)        62 
* superceded by the study of Albert et al., 1998
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The study of middle-aged (45-64) Shanghai men by Yuan et al. (2001) provides an opportunity to contrast 
the effects of eating fish (only) with that of eating shellfish (only).  For heart attack deaths, there was a 
significant negative relationship with weekly intake, regardless of the type of seafood, based on log-log 
regression.  For other ischemic heart disease and stroke deaths, there were no significant relationships with 
either type of seafood.  Since finfish tend to have higher MeHg levels than shellfish (Mahaffey, 2004), this 
study does not support an adverse cardiovascular effect of MeHg.  
As reported by Yoshizawa et al. (2002), Ascherio et al.’s study of health professionals included a 
high proportion of dentists, who tend to have higher exposures of inorganic Hg.  If Hg0 truly had adverse 
effects on coronary heart disease, a stronger response to fish consumption would have been expected. 
 
4.2.2 Gender and Race Effects.  Some possible insights into socioeconomic and lifestyle factors might be 
inferred from the results of Gillum et al. (2000), who analyzed the mortality experience of the first National 
Health and Nutrition Examination Survey (NHANES I) cohort in relation to fish consumption, for a mean 
follow-up of 19 years beginning in the 1970s.  The study involved a nationally representative sample of 
initially healthy adults, ages 25-74.  Most of the studies summarized in Table 2 involved white males, and 
the white men in the NHANES-I cohort showed similar relationships: decreased mortality from all causes, 
CVD, and non-CVD for those eating fish at least once per week and no additional benefit for additional 
consumption.  However, white women showed no significant mortality benefits, nor did black men.  The 
results for black women were similar to those for white men, but failed to reach statistical significance, 
presumably because of the smaller sample.  The combined cohort results (total of 2901 deaths) showed no 
effect for CVD deaths and decreasing mortality with increasing fish consumption for non-CVD deaths, 
with less additional benefit after about one fish meal every two weeks.  These results are suggestive of 
lifestyle effects, since no mechanisms have been postulated for non-CVD deaths and there is no a priori 
reason to suspect gender or racial differences in the effects of fish.      
 
4.3 Estimated Dose-Response Relationships.   
Table 5 is based on responses at or near the mean exposure levels; many of the authors’ conclusions 
are based on risks at the highest exposure levels.  In this section, we examine dose-response relationships 
across the range of each study, assuming a linear response.  Some studies appear to show a significant 
difference between people who eat no fish and those who eat various amounts, with no trend according to 
the rate of consumption.  We would interpret such findings as showing a difference between types of 
subjects, perhaps because of lifestyle differences, rather than an effect of fish consumption per se 
(Hypothesis A1).  The data appear to indicate that high-consumers of fish may tend to be of higher 
socioeconomic status (SES) in developed countries than in poorer countries. 
 
 
Table 6  Relative Mortality Risks from Fish Consumption 
(Based on Table 5) 
 
 
Cause of Death 
   Avoided deaths/ 
      Total deaths 
Relative Risk 
All causes 1061/9279 0.886 
Coronary Heart Disease (CHD) 528/3300 0.840 
Stroke 349/1689 0.793 
 
 
The meta-analysis of Konig et al. (2005) produced a linear dose-response function for CHD 
mortality in which the major effect was between those who did not eat fish and those who ate fish in any 
amount: 
 
RR = 0.83 – 0.039*fish meals per week    (R2 =0.23) [4-1] 
 
This relationship is roughly in agreement with those derived from meta-analyses of randomized control 
trials of supplementary fish oil discussed above.  Such a relationship is also compatible with a log-log 
model with a slope of about –0.09.  This implies that a 10% increase in fish consumption (at any level) is 
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associated with a decrease in CHD mortality of ~0.9%.  A slightly stronger CHD relationship was found by 
He et al. (2004) based on 13 cohorts, over 220,000 individuals, and about 12 years of follow-up: 
 
 RR = 0.94 – 0.048*fish meals per week.  (R2 across quintiles = 0.91) [4-2] 
 
The log-log slope is –0.105 and the trend is highly significant.  Whelton et al. (2004) pooled data from 14 
observational and 5 case-control studies and found a relative risk for fatal CHD of 0.83, for any fish 
consumption vs. “little or no” consumption.  A similar relationship was found for fatal and non-fatal CHD 
combined.  However, the authors referred to fish consumption as a “component of lifestyle modification”, 
suggesting that other factors may be involved (Hypothesis A1 in Table 1).   Osler et al. (2000) reported a 
RR of 0.74 for ischemic heart disease mortality in Denmark, for persons at high risk. 
Bouzan et al. found a much weaker (not significant) meta-relationship for stroke mortality: 
 
 RR = 0.88 - 0.02*fish meals per week    (R2 =0.034) [4-3] 
 
He et al. (2004) also performed a meta-analysis of cohort studies of stroke mortality and found 
striking differences between the two major types of strokes.  Ischemic stroke mortality was reduced by 
about 35% at all levels of fish consumption, while mortality from hemorrhagic strokes increased 
dramatically at small rates of fish consumption.  The net result of a log-log regression of all types of strokes 
combined (by weighted average) was a slope of –0.09 (highly significant trend; R2 across quintiles = 0.94). 
Based on U.S. age-adjusted mortality rates for 2004 and assuming no contributions form non-
CVD causes, the combination of [4-1] and [4-3] would result in a relationship for all-cause mortality of 
 
 RR = 0.95 – 0.012*fish meals per week      [4-4] 
  
This relationship [4-4] implies an all-cause mortality RR of 0.866 for daily consumption of fish.  
An unweighted regression analysis of the data in Table 4 based on the mean or median fish 
consumption in each study produced a negative but nonsignificant relationship between all-cause mortality 
and fish consumption very similar to [4-4], and a log-log relationship for CHD mortality with a slope of –
0.096 after deleting two apparent outliers (the Kromhout studies in the Netherlands). 
 In summary, the association of fish consumption with reduced mortality seems quite clear 
(Hypothesis A in Table 1), even though there is no apparent physiological justification for a log-log 
relationship in which most of the benefit is obtained at relatively low levels of fish consumption.  However, 
the relative roles of other dietary and lifestyle factors that may be correlated with eating fish remain to be 
defined (Hypothesis A1 in Table 1). 
 
4.4 An Ecological Mortality Study   
Ecological studies of average national population risk vs. national averages of risk factors have the 
disadvantage of lacking data on individuals and are thus subject to the “ecological fallacy”, in which the 
individuals having the risk factor in question may have health outcomes that differ significantly from the 
average outcome for the entire group.  However, relative to the generally preferred cohort studies, 
ecological studies have the advantage of the absence of subject selection bias (health professionals, for 
example) and of representing much larger and more diverse populations.  Also, cohort studies have the 
potential problem of early depletion of the most sensitive subjects; for example, the early beneficial effect 
reported by Burr et al. (1989) was based on a difference of only 36 deaths, while 8 years later, the mortality 
increment in this cohort had decreased to 23 deaths and become non-significant (Ness et al., 2002).   
Conclusions based on such small samples are inherently problematic. 
Zhang et al. (1999) used data from 36 (mainly developed) countries, including the United States 
and Canada, to investigate the relationship between fish consumption and mortality.  Dietary data back to 
1961 were obtained from the United Nations Food and Agriculture Organization (FAO), for fish 
consumption, animal protein (less fish), animal fat-fish fat, alcohol consumption, and cigarette sales 
(incomplete data).  The dietary variables were expressed as percentages of total energy intake; on this basis, 
fish consumption ranged from 0.23% (Hungary) to 10.4% (Iceland).  Annual mortality rates by sex were 
standardized to ages 45-74 for all causes, ischemic heart disease (IHD), and cerebrovascular causes (CVA).  
Eastern Europe had the highest mortality rates; Japan and Iceland, the lowest.  The authors concluded that 
 22
“fish consumption is associated with reduced risk from all-cause, ischemic heart disease, and stroke 
mortality at the population level.” 
 We reanalyzed the tabulated data, with and without the Eastern European countries (Hungary, 
Poland, Czech Republic, Bulgaria, Romania), in order to remove any effects of deprivation that might have 
remained from their prior membership in the Soviet block.  We found that log-log models fit the data 
better, as did Zhang et al.  Surprisingly, cigarette consumption was not a significant predictor in the subset 
of countries with data, perhaps because lagged consumption data should have been used to account for the 
latency periods involved.  Fish intake showed a negative (beneficial effect); animal-fish fat, positive 
(harmful) for IHD and negative for stroke; and alcohol was significantly beneficial for IHD mortality, 
harmful for stroke, with no effect on all-cause mortality.  Figure 3 is a scatter plot of all-cause mortality vs. 
fish consumption.  Without the five Eastern European countries, the all-cause, log-log regression 
coefficients were -0.077 for males and –0.061 for females.   These estimates are not significantly different 
from the –0.09 to –0.11 values reported above for cohort studies.  For all-cause mortality, fish consumption 
was the most important predictor; for IHD deaths, animal-fish fats (positive); for stroke, animal-fish fats 
(negative). 
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Figure 3  Scatter plot of national population data from Zhang et al. (1999), showing all-cause mortality 
rates as a function of fish consumption. 
 
 
 We used these relationships to derive a simulated dose-response function for IHD mortality vs. 
fish consumption, to demonstrate how the benefit levels off at high levels of fish consumption (Figure 4). 
(For reference, the mean fish consumption value for the United States is 0.7% of daily energy intake.)  
However, this is not the case with the (harmful) effects of animal fat (Figure 5), for which the US level is 
20.5% of energy intake. 
 In a similar study, Zhang et al. (2000) reported showed significant reductions in male lung cancer 
mortality associated with fish consumption in countries with high rates of smoking or consumption of 
animal fats.      
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Figure 4  Dose-response functions based on log-log regression models of the data of Zhang et al. (1999).   
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Figure 5 Scatter plot of national population data from Zhang et al. (1999), showing ischemic heart disease 
mortality rates as a function of net animal fat consumption. 
 
 
5.  Results from Studies of Specific Diets 
 
5.1 Studies of Various Complete Diets.   
Observational studies involving complete diets rather than selected constituents offer the opportunity 
to examine interactions among major food groups.  Since diet may be considered a “zero-sum” game, such 
interactions may be important.  For example, Barberger-Gateau et al. (2005) showed that French fish 
consumers tended to have higher education and income levels, eat more fruits and vegetables, consume 
more alcohol, and to feel better about their health.  However, there was a significant positive association 
between fish and meat consumption, and the physical health status of fish eaters was no better.  
Fung et al. (2001) used data from the Nurses Health Study (n = 69017 females) to synthesize two 
model dietary patterns.  The “prudent” diet pattern was characterized by higher intakes of fruits, vegetables, 
legumes, fish, poultry, and whole grains.  The “Western” pattern included more meat, sweets, french fries, 
and refined grains.  Each individual in the cohort was given a score for each of the patterns, and they were 
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grouped into quintiles.  Proportional hazard modeling was then used to define associations of each quintile 
with new cases of CHD.  Figure 6 shows the relative CHD risks associated with each quintile (taken 
separately); the benefits of the “prudent” diet are seen to level off at an RR of 0.76, while the increased 
risks of the “Western” diet continue to rise.  This suggests that dietary benefits may be limited, while 
dietary harm is apparently not.   
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Figure 6  Quintile relative risks from the Nurses Health Study (Fung et al., 2001) for two synthesized diets. 
 
Fung et al. also analyzed the two factors jointly in order to examine interactions, providing 16 
estimates of various combinations of the two diets (the highest 2 quintiles were combined).  This showed 
that for diets with high “western” scores, additional use of the prudent diet had little benefit (Figure 7), 
while at the highest levels of the “prudent” diet, only the highest “western” group reduced the “prudent” 
benefit.  Finally, Fung et al. provided data on the major constituents of the two diets, which we used in 
additional regression analysis.  The best predictor of relative risk of CHD was the difference between meat 
and fish consumption (servings per day), for which the correlation was about 0.6 (n=10).  Other “healthy” 
diet constituents (fruits, vegetables, whole grains) made little improvement (Figure 8).  In a personal 
communication (September, 2006), Dr. Fung confirmed that red meat seemed to be the most important 
factor in this study.  
 
 25
0.5
0.55
0.6
0.65
0.7
0.75
0.8
0.85
0.9
0.95
1
1 2 3 4,5
prudent diet (fish) quintile
re
la
tiv
e 
ri
sk
 o
f C
H
D
 
Figure 7  Quintile relative risks from the Nurses Health Study (Fung et al., 2001) showing the interactions 
among adherents to two synthesized diets. 
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Figure 8    Relative risks of coronary heart disease from the Nurses Health Study (Fung et al.2001) showing 
the relative importance of meat consumption and other “healthy” foods. 
 
 
5.2  Studies of the “Mediterranean Diet” 
The so-called “Mediterranean Diet” has received a great deal of attention in the literature.  
MEDLINE lists 420 English language papers for which this phrase appears in the title or abstract, of which 
128 are classified as review papers.  This diet features olive oil, red wine, fruits and vegetables, cereals, 
nuts, fish and chicken, and only small amounts of red meat, dairy products, or eggs (American Heart 
Association, 2006).  Serra-Majem et al. (2006) reviewed 43 papers on various aspects of this diet. 
 Several intervention studies have involved the Mediterranean diet.  For example, Knoops et al. 
(2004) reported a 23% lower mortality rate (RR=0.77) for elderly individuals who adhered to this diet for 
10 years.  The relative risk for CHD was 0.61.  Adherence to this diet in combination with moderate 
alcohol consumption, not smoking, and physical activity produced a RR of 0.35 in this cohort.  The 
separate contribution of fish consumption was not identified. 
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Kok and Kromhout (2004) identified a variant of this diet in a cohort from Crete and reported a 
RR of 0.3 for all-cause and cardiac mortality.  This diet included 18 g/d of fish (about 1 meal/wk).  In a 
much larger study of about 75,000 elderly residents of 9 European countries, Trichopoulou et al. (2005) 
reported an overall all-cause RR of 0.83 for those who adhered most closely to a modified Mediterranean 
diet that included about 37 g/d of fish.  The RRs were lowest for residents of Greece and Denmark (0.69, 
0.71).  
 
6.  Concluding Discussion   
 
The evidence for adverse cardiovascular effects of MeHg is sparse and unconvincing.  The studies 
of CVD, IHD, and CVD mortality show net benefits (Table 3); there are no plausible rationales for adverse 
effects on other major causes of death.  The finding of adverse effects in Finland at high Hg exposure levels 
requires replication in another setting prior to use for policy purposes.  There is no convincing evidence for 
adverse Hg effects on blood pressure or heart rate, and the Hg effects on heart rate variability and 
atherosclerosis are mixed. 
 By contrast, a very consistent picture of beneficial effects is seen for omega-3 PUFAs, after 
recognizing the effects of exposure uncertainties and the presence of thresholds in the baseline range of 3-
5% of total fatty acids (Figure 2).  Studies based on measured biomarker levels are seen to be the most 
reliable and present a convincing picture of strong beneficial effects, especially for those causes of death 
involving arrhythmias.  This conclusion extends to studies of fish-oil supplementation, for which 
measurements of biomarker levels are also needed. 
 Studies based on fish consumption per se are expected to display the net effects of (potentially) 
adverse effects of MeHg and the beneficial effects of n-3 PUFAs.  This distinction is difficult to study 
separately, since the two factors tend to be positively correlated within a population (they are linked by 
variations in the rates of fish consumption).  These cohort studies show net benefits from increased fish 
consumption (Table 6), for all-cause, CHD, and CVD mortality.  This finding is supported by an ecological 
study at the population level (Figure 4), for which the lifestyle effects that might be correlated with fish 
consumption within a given population would be expected to “average out.” 
 Finally, the net survival benefits resulting from eating fish are consistent with studies involving 
complete diets, although benefits are also seen to accrue from reducing consumption of red meat and 
saturated fats. 
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Appendix   List of Abbreviations and Acronyms 
 
ALA    α-linolenic acid (a PUFA found in plants) 
AMI  acute myocardial infarction (heart attack) 
CHD  coronary heart disease 
CVD  cardiovascular disease (CHD + strokes) 
DHA  docosahexaenoic acid   | 
DPA  docasapentaenoic acid  |   PUFAs found in fish 
EPA  eicosapentaenoic acid   | 
EURAMIC European Multicenter Case-Control Study on Antioxidants, Myocardial Infarction,  
  and Cancer of the Breast 
Hg  mercury 
Hg0  elemental mercury 
HRV  heart rate variability 
IHD  ischemic heart disease  (a subset of CHD) 
IMT  intima media thickness 
IQ  intelligence quotient 
KIHD  Kuopio (Finland) Ischemic Heart Disease Risk Factor Study 
MeHg  methylmercury 
MI  myocardial infarction (heart attack) 
MRFIT  Multiple Risk Factor Intervention Trial 
NHANES National Health and Nutrition Examination Survey 
omega-3 molecular structure notation for PUFAs (also denoted n-3) 
OR  odds ratio (the ratio of cases to controls) 
p-value  the probability of differing from zero 
PCB  polychlorinated biphenyl 
Pb  lead 
PUFA  polyunsaturated fatty acid 
R  correlation coefficient (R2 = the proportion of variance explained by the  
  relationship) 
RBC  red blood cells  
RCT  randomized controlled trial 
RR  relative risk (the ratio of outcomes with the factor in question to those without) 
    RRs > 1 represent “positive” relationships; RRs < 1 represent “negative”  
  relationships  
Se  selenium 
(xxx-yyy) 95% confidence intervals  
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